Canaccord raised the firm’s price target on Staar Surgical (STAA) to $20 from $17 and keeps a Hold rating on the shares. The firm said they delivered an expectedly tough Q1 in terms of its results, but the tone of the earnings call was more upbeat than expected especially given that guidance was withdrawn, and as a result, the firm is taking its estimates up.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA: